How does drug resistance to targeted therapy occur?
Thursday, November 21, 2024
Burnett lab members
The Burnett lab. Front row: Ziyu Wang, Andrean Simons-Burnett, Nourin Khan, and Krishna Awasthi.Back row: Martin Smalley, Nafis Md Irfan,  Md Roman Mogal, and Jay Seapoo.

Congratulations to Andrean Simons-Burnett, PhD who is the recipient of a $1,768,815 R01 grant from the National Institute of Dental and Craniofacial Research. 

The award will support her project "Inflammation and EGFR crosstalk in HNSCC Therapy," which seeks to understand how drug resistance to targeted therapy occurs and develop new strategies to allow these therapies to work. Well done to her and to her research team for winning this grant!